Literature DB >> 22875281

VAS2870 is a pan-NADPH oxidase inhibitor.

Kirstin Wingler, Sebastian A Altenhoefer, Pamela W M Kleikers, Kim A Radermacher, Christoph Kleinschnitz, Harald H H W Schmidt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22875281     DOI： 10.1007/s00018-012-1107-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN： 1420-682X            Impact factor:   9.261


× No keyword cloud information.
  7 in total

Review 1.  NADPH oxidases as therapeutic targets in ischemic stroke.

Authors:  Timo Kahles; Ralf P Brandes
Journal:  Cell Mol Life Sci       Date:  2012-05-23       Impact factor: 9.261

2.  Novel Nox inhibitor of oxLDL-induced reactive oxygen species formation in human endothelial cells.

Authors:  Claudia Stielow; Rusan A Catar; Gregor Muller; Kirstin Wingler; Peter Scheurer; Harald H H W Schmidt; Henning Morawietz
Journal:  Biochem Biophys Res Commun       Date:  2006-03-29       Impact factor: 3.575

3.  Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.

Authors:  Christoph Kleinschnitz; Henrike Grund; Kirstin Wingler; Melanie E Armitage; Emma Jones; Manish Mittal; David Barit; Tobias Schwarz; Christian Geis; Peter Kraft; Konstanze Barthel; Michael K Schuhmann; Alexander M Herrmann; Sven G Meuth; Guido Stoll; Sabine Meurer; Anja Schrewe; Lore Becker; Valérie Gailus-Durner; Helmut Fuchs; Thomas Klopstock; Martin Hrabé de Angelis; Karin Jandeleit-Dahm; Ajay M Shah; Norbert Weissmann; Harald H H W Schmidt
Journal:  PLoS Biol       Date:  2010-09-21       Impact factor: 8.029

4.  Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.

Authors:  S Wind; K Beuerlein; T Eucker; H Müller; P Scheurer; M E Armitage; H Ho; H H H W Schmidt; K Wingler
Journal:  Br J Pharmacol       Date:  2010-10       Impact factor: 8.739

5.  Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.

Authors:  Henrik ten Freyhaus; Michael Huntgeburth; Kirstin Wingler; Jessika Schnitker; Anselm T Bäumer; Marius Vantler; Mohamed M Bekhite; Maria Wartenberg; Heinrich Sauer; Stephan Rosenkranz
Journal:  Cardiovasc Res       Date:  2006-03-20       Impact factor: 10.787

Review 6.  The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.

Authors:  Sebastian Altenhöfer; Pamela W M Kleikers; Kim A Radermacher; Peter Scheurer; J J Rob Hermans; Paul Schiffers; Heidi Ho; Kirstin Wingler; Harald H H W Schmidt
Journal:  Cell Mol Life Sci       Date:  2012-05-31       Impact factor: 9.261

Review 7.  NOX1, 2, 4, 5: counting out oxidative stress.

Authors:  K Wingler; J J R Hermans; P Schiffers; Al Moens; M Paul; H H H W Schmidt
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739
  7 in total
  31 in total

1.  Myocardin-related Transcription Factor Regulates Nox4 Protein Expression: LINKING CYTOSKELETAL ORGANIZATION TO REDOX STATE.

Authors:  Matthew Rozycki; Janne Folke Bialik; Pam Speight; Qinghong Dan; Teresa E T Knudsen; Stephen G Szeto; Darren A Yuen; Katalin Szászi; Stine F Pedersen; András Kapus
Journal:  J Biol Chem       Date:  2015-11-10       Impact factor: 5.157

Review 2.  New insights on NOX enzymes in the central nervous system.

Authors:  Zeynab Nayernia; Vincent Jaquet; Karl-Heinz Krause
Journal:  Antioxid Redox Signal       Date:  2014-01-16       Impact factor: 8.401

3.  Amputation-induced reactive oxygen species signaling is required for axolotl tail regeneration.

Authors:  Nour W Al Haj Baddar; Adarsh Chithrala; S Randal Voss
Journal:  Dev Dyn       Date:  2018-12-21       Impact factor: 3.780

Review 4.  Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2.

Authors:  Federico Carbone; Priscila Camillo Teixeira; Vincent Braunersreuther; François Mach; Nicolas Vuilleumier; Fabrizio Montecucco
Journal:  Antioxid Redox Signal       Date:  2014-04-22       Impact factor: 8.401

Review 5.  Nox Inhibitors & Therapies: Rational Design of Peptidic and Small Molecule Inhibitors.

Authors:  M Eugenia Cifuentes-Pagano; Daniel N Meijles; Patrick J Pagano
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

6.  Inhibiting the Activity of NADPH Oxidase in Cancer.

Authors:  Mariam M Konaté; Smitha Antony; James H Doroshow
Journal:  Antioxid Redox Signal       Date:  2020-04-17       Impact factor: 8.401

Review 7.  Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress.

Authors:  Kim A Radermacher; Kirstin Wingler; Friederike Langhauser; Sebastian Altenhöfer; Pamela Kleikers; J J Rob Hermans; Martin Hrabě de Angelis; Christoph Kleinschnitz; Harald H H W Schmidt
Journal:  Antioxid Redox Signal       Date:  2012-10-16       Impact factor: 8.401

Review 8.  Updates of reactive oxygen species in melanoma etiology and progression.

Authors:  Feng Liu-Smith; Ryan Dellinger; Frank L Meyskens
Journal:  Arch Biochem Biophys       Date:  2014-04-26       Impact factor: 4.013

9.  Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release.

Authors:  Michelle J Connolly; Jesus Prieto-Lloret; Silke Becker; Jeremy P T Ward; Philip I Aaronson
Journal:  J Physiol       Date:  2013-06-17       Impact factor: 5.182

Review 10.  NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress.

Authors:  Becky A Diebold; Susan M E Smith; Yang Li; J David Lambeth
Journal:  Antioxid Redox Signal       Date:  2014-03-24       Impact factor: 8.401
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.